CRME

BRIEF-Cardiome CEO sells shares to meet margin call - 11/28 - 05:34 PM ET

CRME: Q3 Earnings Call @ 09:00 ET Today [delayed] - 11/17 - 08:34 AM ET

BRIEF-Cardiome reports third quarter results - 11/14 - 06:44 PM ET

Cardiome Pharma Climbs Over Recent Resistance On Increased Volume - 08/21 - 11:33 AM ET

CRME: Q2 Earnings Call @ 16:30 ET Today [delayed] - 08/12 - 01:50 PM ET

Cardiome Pharma plunges after FDA requests safety update for Kynapid - 08/11 - 10:10 AM ET

COM: FDA Approvable Letter For KYNAPID(TM) - 08/11 - 09:28 AM ET

Cardiome Pharma Plummets In Pre-Market - 08/11 - 09:21 AM ET

Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM) - 08/11 - 09:18 AM ET

Cardiome Pharma Corp reports financing of preferred share - 07/24 - 05:27 AM ET

Cardiome Pharma Breaks Resistance, Hits 8-Month High - 07/21 - 12:10 PM ET

Cardiome Pharma downgraded to sector perform at RBC Capital Markets - 07/16 - 07:58 AM ET

Cardiome Pharma Finishes At Highest Level Since Late June - 07/14 - 04:22 PM ET

CRME: Positive Phase 2b Results For Oral Vernakalant - 07/14 - 09:05 AM ET

Cardiome Pharma Jumps In Pre-Market On Positive Tests Results On Oral Vernakalant - 07/14 - 09:00 AM ET

Cardiome Announces Positive Phase 2b Results For Oral Vernakalant - 07/14 - 08:25 AM ET

CRME: Q2 Earnings Call @ 09:00 ET Today [delayed] - 07/14 - 02:18 AM ET

Cardiome To Hold Conference Call - 07/13 - 12:00 PM ET

CRME: Positive Interim Results from Ph 2B Study of Vernakalant - 06/03 - 07:57 AM ET

K I L L K I L L K I L L -- Cardiome Pharma Corp. - 06/03 - 04:32 AM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index